Lv1
60 积分 2024-09-05 加入
Combination locoregional and systemic therapies in hepatocellular carcinoma
1天前
已完结
FlexiPlasma Microcatheter–Embolic Material (FPM‐EM) Platform: A Non‐Inflammatory Pyroptosis Strategy for Precision Hepatocellular Carcinoma Therapy
1天前
已完结
Synergistic Effects of Transarterial Chemoembolization and Lenvatinib on HIF-1α Ubiquitination and Prognosis Improvement in Hepatocellular Carcinoma
1天前
已完结
Role of locoregional therapies in the wake of systemic therapy
1天前
已完结
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
1天前
已完结
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
1天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
1天前
已完结
Next‐Generation Flexible Embolic Systems: Targeted Transarterial Chemoembolization Strategies for Hepatocellular Carcinoma
1天前
已完结
BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update
2天前
已完结
Microbial metabolism dysfunction induced by transarterial chemoembolization aggravates postprocedural liver injury in HCC
2天前
已完结
皖公网安备34019202002308
